Launch-at-Risk Analysis for Generic Pharmaceutical Company

Background

Secretariat worked with a generic pharmaceutical company to evaluate potential risks and rewards in an “launch-at-risk” generic drug. Secretariat’s complex, scenario-based modeling provided key insights and drove economically informed decision making.

Latest Insights

Talk to Our Insightful Experts